Product Program year 2021 Source: CMS Open Payments

Solyx Blue

Device Stress Urinary Incontinence

Open in the dashboard

General payments

$9,936

345 payments

Research payments

$0

0 payments

Through program year 2021, $9,936 in general payments and $0 in research payments were reported against Solyx Blue (Stress Urinary Incontinence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2021 General $115 3
2020 General $4,939 178
2019 General $4,881 164

Breakdown

Who paid General payments · program years 2019–2021
  1. Boston Scientific Corporation $9,936 345 payments
Top recipients General payments · program year 2021
  1. Lauren Caldwell Urogynecology and Reconstructive Pelvic Surgery · Austin, TX $85 73% · 1 payment
  2. Rahul Dutta Urogynecology and Reconstructive Pelvic Surgery · Winston Salem, NC $18 15% · 1 payment
  3. Isaac Kelly Urology · Upland, CA $13 11% · 1 payment

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $85 73% · 1 practitioner
  2. Urogynecology and Reconstructive Pelvic Surgery Urology $18 15% · 1 practitioner
  3. Urology $13 11% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Texas $85 73% · 1 recipient
  2. North Carolina $18 15% · 1 recipient
  3. California $13 11% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

345 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record